New insights into renal transport of urate

Current Opinion in Rheumatology

Volumn 19, Issue 2, 2007, Pages 151-157

  Anzai, Naohiko ^a   Kanai, Yoshikatsu ^a   Endou, Hitoshi ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

OAT; Renal urate transport; SLC22A12; URAT1

Indexed keywords

2,4 DICHLOROPHENOXYACETIC ACID; ABC TRANSPORTER; ALLOPURINOL; BENZBROMARONE; DIURETIC AGENT; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OXIPURINOL; PDZ PROTEIN; PENICILLIN G; PHENYLBUTAZONE; POSTSYNAPTIC DENSITY PROTEIN 95; PRASTERONE; PROBENECID; PROTEIN ZO1; SULFINPYRAZONE; URATE;

DNA SCREENING; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HYPOURICEMIA; KIDNEY TUBULE ABSORPTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TRANSCRIPTION REGULATION; TRANSPORT KINETICS; URIC ACID URINE LEVEL;

HUMANS; KIDNEY; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE I; URIC ACID;

EID: 33846837206     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328032781a     Document Type: Review

References (72)

1. Sica DA, Schoolwerth AC. Real handling of organic anions and cations: excretion of uric acid. In: Brenner BM, editor. The kidney. 6th ed. Philadelphia: WB Saunders; 2000. pp. 680-700.
2. Maesaka JK, Fishbane S. Regulation of renal urate excretion: A critical review. Am J Kidney Dis 1998; 32:917-933.
3. Abramson RG, Lipkowitz MS. Evolution of the uric acid transport mechanisms in vertebrate kidney. In: Kinne RKH, editor. Basic principles in transport, comparative physiology. Volume 3. Basel: Karger; 1990. pp. 115-153.
4. Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417:447-452.
5. Roch-Ramel F, Guisan B. Renal transport of urate in humans. News Physiol Sci 1999; 14:80-84.
6. Rafey MA, Lipkowitz MS, Leal-Pinto E, Abramson RG. Uric acid transport. Curr Opin Nephrol Hypertens 2003; 12:511-516.
7. Anzai N, Enomoto A, Endou H. Renal urate handling: Clinical relevance of recent advances. Curr Rheumatol Rep 2005; 7:227-234. This is a concise review focusing on the urate transport system in the kidneys.
8. Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology (Bethesda) 2005; 20:125-133. This is the extensive review on urate transport including the physiological importance of urate in the body.
9. Mount DB. Molecular physiology and the four-component model of renal urate transport. Curr Opin Nephrol Hypertens 2005; 14:460-463. This is an excellent review focusing on the significance of the four-component model in the post hURAT1 era.
10. Enomoto A, Endou H. Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol 2005; 9:195-205.
11. Capasso G, Jaeger P, Robertson WG, Unwin RJ. Uric acid and the kidney: urate transport, stone disease and progressive renal failure. Curr Pharm Des 2005; 11:4153-4159. This paper provides information on renal urate transport and urate-related kidney diseases.
12. Mount DB, Kwon CY, Zandi-Nejad K. Renal urate transport. Rheum Dis Clin North Am 2006; 32:313-331. This is an extensive review with regard to various aspects of renal urate transport.
13. Terkeltaub R, Bushinsky DA, Becker MA. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther 2006; 8 (Suppl 1):S4. The relation between real urate transport and the development of novel atihyperuricemic therapeutics is described in this paper.
14. Sperling O. Hereditary renal hypouricemia. Mol Genet Metab 2006; 89:14-18. This is a concise review focusing on URAT1 and renal hypouricemia.
15. Ichida K, Hosoyamada M, Hisatome I, et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan - Influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004; 15:164-173.
16. Komoda F, Sekine T, Inatomi J, et al. The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr Nephrol 2004; 19:728-733.
17. Hosoyamada M, Ichida K, Enomoto A, et al. Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol 2004; 15:261-268.
18. Imaoka T, Kusuhara H, Adachi-Akahane S, et al. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. J Am Soc Nephrol 2004; 15:2012-2022.
19. Cha SH, Sekine T, Kusuhara H, et al. Molecular cloning and characterization of multispecific orgaic anion transporter 4 expressed i the placenta. J Biol Chem 2000; 275:4507-4512.
20. Ekaratanawong S, Anzai N, Jutabha P, et al. Human orgaic anion transporter 4 is a real apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 2004; 94:297-304.
21. - exchange [abstract]. FASEB J 2006; 20:A340.
22. Lipkowitz MS, Leal-Pinto E, Cohen BE, Abramson RG. Galectin 9 is the sugar-regulated urate transporter/channel UAT. Glycoconj J 2004; 19:491-498.
23. Hyink DP, Rappoport JZ, Wilson PD, Abramson RG. Expression of the urate transporter/channel is developmentally regulated in human kidneys. Am J Physiol Renal Physiol 2001; 281:F875-F886.
24. Jutabha P, Kanai Y, Hosoyamada M, et al. Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule. J Biol Chem 2003; 278:27930-27938.
25. Jutabha P, Chairoungdua A, Anzai N, Kanai Y. The voltage-driven organic anion transport of type I sodium-phosphate cotransporter and OATv1 [abstract]. FASEB J 2006; 20:A1235.
26. Van Aubel RA, Smeets PH, van den Heuvel JJ, Russel FG. Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am J Physiol Renal Physiol 2005; 288:F327-F333. This paper provides the first evidence that human MRP4 is a renal urate transporter.
27. Hosoyamada M, Sekine T, Kanai Y, Endou H. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol Renal Physiol 1999; 276:F122-F128.
28. Cha SH, Sekine T, Fukushima JI, et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 2001; 59:1277-1286.
29. Ichida K, Hosoyamada M, Kimura H, et al. Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int 2003; 63:143-155.
30. Sekine T, Watanabe N, Hosoyamada M, et al. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997; 272:18526-18529.
31. Bakhiya N, Bahn A, Burckhardt G, Wolff NA. Human organic aniontransporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate efflux. Cell Physiol Biochem 2003; 13:249-256.
32. Zhang X, Groves CE, Bahn A, et al. Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule. Am J Physiol Renal Physiol 2004; 287:F999-F1010.
33. Hart TC, Gorry MC, Hart PS, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 2002; 39:882-892.
34. Rampoldi L, Caridi G, Santon D, et al. Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. Hum Mol Genet 2003; 12:3369-3384.
35. Kudo E, Kamatani N, Tezuka O, et al. Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese families. Kidney Int 2004; 65:1589-1597.
36. Scolari F, Caridi G, Rampoldi L, et al. Uromodulin storage diseases: clinical aspects and mechanisms. Am J Kidney Dis 2004; 44:987-999.
37. Gersch MS, Sautin YY, Gersch CM, et al. Does Tamm-Horsfall protein-uric acid binding play a significant role in urate homeostasis? Nephrol Dial Transplant 2006; 21:2938-2942.
38. Kahn AM, Weinman EJ. Urate transport in the proximal tubule: in vivo and vesicle studies. Am J Physiol Renal Physiol 1985; 249:F789-F798.
39. Gopal E, Fei YJ, Sugawara M, et al. Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate. J Biol Chem 2004; 279:44522-44532.
40. Srinivas SR, Gopal E, Zhuang L, et al. Cloning and functional identification of slc5a12 as a sodium-coupled low-affinity transporter for monocarboxylates (SMCT2). Biochem J 2005; 392:655-664.
41. Zandi-Nejad K, Plata C, Enck AH, et al. Slc5a8 functions as a sodium-dependent pyrazionate and nicotinate cotransporter; Implications for renal urate transport [abstract]. J Am Soc Nephrol 2004; 15:89A.
42. Thangaraju M, Ananth S, Martin PM, et al. c/ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney. J Biol Chem 2006; 281:26769-26773. The fuctional coupling between lactate reabsorption and urate reabsorption in renal proximal tubules is described in this paper.
43. Russel FG, Masereeuw R, van Aubel RA. Molecular aspects of renal anionic drug transport. Annu Rev Physiol 2002; 64:563-594.
44. Anzai N, Jutabha P, Kanai Y, Endou H. Integrated physiology of proximal tubular organic anion transport. Curr Opin Nephrol Hypertens 2005; 14:472-479. This paper focuses on the role of PDZ proteins in multimolecular complex formation at the apical membrane of renal proximal tubules.
45. Anzai N, Miyazaki H, Noshiro R, et al. The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C-terminal. J Biol Chem 2004; 279:45942-45950.
46. Miyazaki H, Anzai N, Ekaratanawong S, et al. Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J Am Soc Nephrol 2005; 16:3498-3506.
47. Jutabha P, Anzai N, Endou H, et al. Interaction of the multivalent PDZ domain protein PDZK1 with type I sodium-phosphate cotransporter (NPT1) [abstract]. J Am Soc Nephrol 2005; 16:350A.
48. Anzai N, Miyazaki H, He X, et al. Identification of the multivalent PDZ domain protein PDZK1 as a binding partner of sodium-coupled monocarboxylate cotransporter 1 (SMCT1) [abstract]. J Am Soc Nephrol 2006; 17:266A.
49. Anzai N, Kanai Y, Endou H. Organic anion transporter family: current knowledge. J Pharmacol Sci 2006; 100:411-426. This is an extensive review on the current understanding of the renal organic anion transporter OAT family.
50. Li T, Walsh JR, Ghishan FK, Bai L. Molecular cloning and characterization of a human urate transporter (hURAT1) gene promoter. Biochim Biophys Acta 2004; 1681:53-58.
51. Eraly SA, Hamilton BA, Nigam SK. Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochem Biophys Res Commun 2003; 300:333-342.
52. Maher JM, Slitt AL, Callaghan TN, et al. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. Biochem Pharmacol 2006; 72:512-522. This paper provides evidence that OAT family members are trascriptionally regulated by HNF1.
53. Kikuchi R, Kusuhara H, Hattori N, et al. Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha/beta and DNA methylation. Mol Pharmacol 2006; 70:887-896. This paper provides evidence that OAT family members are trascriptionally regulated by HNF1.
54. Pontoglio M, Barra J, Hadchouel M, et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 1996; 84:575-585.
55. Nakashima M, Uematsu T, Kosuge K, Kanamaru M. Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects. Eur J Clin Pharmacol 1992; 42:333-335.
56. Iwanaga T, Kobayashi D, Hirayama M, et al. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Drug Metab Dispos 2005; 33:1791-1795.
57. Prabhakaran D, Anand SS. The metabolic syndrome: an emerging risk state for cardiovascular disease. Vasc Med 2004; 9:55-68.
58. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78:25-29.
59. Johnson RJ, Kag DH, Feig D, et al. Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease? Hypertesion 2003; 41:1183-1190.
60. Ter Maaten JC, Voorburg A, Heine RJ, Ter Wee PM, et al. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 1997; 92:51-58.
61. Tanaka M, Itoh K, Matsushita K, et al. Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. Am J Kidney Dis 2003; 42:1287-1292.
62. Iwai N, Mino Y, Hosoyamada M, et al. A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int 2004; 66:935-944.
63. Wakida N, Tuyen DG, Adachi M, et al. Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia. J Clin Endocrinol Metab 2005; 90:2169-2174.
64. Ishikawa I, Nakagawa M, Hayama S, et al. Acute renal failure with severe loin pain and patchy renal ischaemia after anaerobic exercise (ALPE) (exercise-induced acute renal failure) in a father and child with URAT1 mutations beyond the W258X mutation. Nephrol Dial Transplant 2005; 20:1015.
65. Takahashi T, Tsuchida S, Oyamada T, et al. Recurrent URAT1 gene mutations and prevalence of renal hypouricemia in Japanese. Pediatr Nephrol 2005; 20:576-578.
66. Cheong HI, Kang JH, Lee JH, et al. Mutational analysis of idiopathic renal hypouricemia in Korea. Pediatr Nephrol 2005; 20:886-890.
67. Komatsuda A, Iwamoto K, Wakui H, et al. Analysis of mutations in the urate transporter 1 (URAT1) gene of Japanese patients with hypouricemia in northern Japan and review of the literature. Ren Fail 2006; 28:223-227.
68. Taniguchi A, Urano W, Yamanaka M, et al. A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout. Arthritis Rheum 2005; 52:2576-2577.
69. Graessler J, Graessler A, Unger S, et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006; 54:292-300. This paper provides the first evidence that genetic variations of URAT1 are related to reduced renal uric acid excretion and hyperuricemia.
70. Vazquez-Mellado J, Jimenez-Vaca AL, Cuevas-Covarrubias S, et al. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) (in press).
71. Shima Y, Teruya K, Ohta H. Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 2006; 79:2234-2237.
72. Anzai N, Nilwarangkoon S, Miura D, et al. Human urate transporter URAT1 mediates the transport of salicylate [abstract]. J Pharmacol Sci (in press).